225 related articles for article (PubMed ID: 17977009)
21. Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic beta1 -selective receptor blockade.
Cosentino F; Bonetti S; Rehorik R; Eto M; Werner-Felmayer G; Volpe M; Lüscher TF
J Hypertens; 2002 Mar; 20(3):421-8. PubMed ID: 11875309
[TBL] [Abstract][Full Text] [Related]
22. Nephroprotective effects of nebivolol in 2K1C rats through regulation of the kidney ROS-ADMA-NO pathway.
Wang Y; Niu M; Yin S; Zhang F; Shi R
Pharmacol Rep; 2018 Oct; 70(5):917-929. PubMed ID: 30099298
[TBL] [Abstract][Full Text] [Related]
23. Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension.
Pullamsetti S; Kiss L; Ghofrani HA; Voswinckel R; Haredza P; Klepetko W; Aigner C; Fink L; Muyal JP; Weissmann N; Grimminger F; Seeger W; Schermuly RT
FASEB J; 2005 Jul; 19(9):1175-7. PubMed ID: 15827267
[TBL] [Abstract][Full Text] [Related]
24. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
Lind L; Ingelsson E; Kumar J; Syvänen AC; Axelsson T; Teerlink T
Vasc Med; 2013 Aug; 18(4):192-9. PubMed ID: 23892448
[TBL] [Abstract][Full Text] [Related]
25. Experimental evidences of nitric oxide-dependent vasodilatory activity of nebivolol, a third-generation beta-blocker.
Ignarro LJ
Blood Press Suppl; 2004 Oct; 1():2-16. PubMed ID: 15587107
[TBL] [Abstract][Full Text] [Related]
26. The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension.
Kandavar R; Higashi Y; Chen W; Blackstock C; Vaughn C; Sukhanov S; Sander GE; Roffidal LE; Delafontaine P; Giles TD
J Am Soc Hypertens; 2011; 5(3):161-5. PubMed ID: 21251896
[TBL] [Abstract][Full Text] [Related]
27. Homocysteine-induced hypermethylation of DDAH2 promoter contributes to apoptosis of endothelial cells.
Jia SJ; Lai YQ; Zhao M; Gong T; Zhang BK
Pharmazie; 2013 Apr; 68(4):282-6. PubMed ID: 23700795
[TBL] [Abstract][Full Text] [Related]
28. Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: Role of antioxidant activity.
Mason RP; Kubant R; Jacob RF; Walter MF; Boychuk B; Malinski T
J Cardiovasc Pharmacol; 2006 Jul; 48(1):862-9. PubMed ID: 16891916
[TBL] [Abstract][Full Text] [Related]
29. Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats.
Oelze M; Daiber A; Brandes RP; Hortmann M; Wenzel P; Hink U; Schulz E; Mollnau H; von Sandersleben A; Kleschyov AL; Mülsch A; Li H; Förstermann U; Münzel T
Hypertension; 2006 Oct; 48(4):677-84. PubMed ID: 16940222
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia causes increased monocyte nitric oxide synthesis which is mediated by changes in dimethylarginine dimethylaminohydrolase 2 expression in animal and human models of normobaric hypoxia.
Lambden S; Martin D; Vanezis K; Lee B; Tomlinson J; Piper S; Boruc O; Mythen M; Leiper J
Nitric Oxide; 2016 Aug; 58():59-66. PubMed ID: 27319282
[TBL] [Abstract][Full Text] [Related]
31. Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells.
Mollnau H; Schulz E; Daiber A; Baldus S; Oelze M; August M; Wendt M; Walter U; Geiger C; Agrawal R; Kleschyov AL; Meinertz T; Münzel T
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):615-21. PubMed ID: 12692005
[TBL] [Abstract][Full Text] [Related]
32. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
Hasegawa K; Wakino S; Tatematsu S; Yoshioka K; Homma K; Sugano N; Kimoto M; Hayashi K; Itoh H
Circ Res; 2007 Jul; 101(2):e2-10. PubMed ID: 17601800
[TBL] [Abstract][Full Text] [Related]
33. Correlations of DDAH1 transcript variants with human endothelial asymmetric dimethylarginine metabolizing activity.
Sun T; Zhou JP; Kuang DB; Li MP; Xiong Y; Tang J; Xia J; Bai YP; Yang GP; Li YJ; Chen XP
Am J Hypertens; 2013 Dec; 26(12):1437-44. PubMed ID: 23864585
[TBL] [Abstract][Full Text] [Related]
34. All-trans retinoic acid inhibits cobalt chloride-induced apoptosis in PC12 cells: role of the dimethylarginine dimethylaminohydrolase/asymmetric dimethylarginine pathway.
Wang S; Hu CP; Jiang DJ; Peng J; Zhou Z; Yuan Q; Nie SD; Jiang JL; Li YJ; Huang KL
J Neurosci Res; 2009 Jun; 87(8):1938-46. PubMed ID: 19156866
[TBL] [Abstract][Full Text] [Related]
35. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
Oğuz A; Uzunlulu M; Yorulmaz E; Yalçin Y; Hekim N; Fici F
Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
[TBL] [Abstract][Full Text] [Related]
36. Evidence for a protective role for the rs805305 single nucleotide polymorphism of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in septic shock through the regulation of DDAH activity.
Lambden S; Tomlinson J; Piper S; Gordon AC; Leiper J
Crit Care; 2018 Dec; 22(1):336. PubMed ID: 30538005
[TBL] [Abstract][Full Text] [Related]
37. Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X.
Sen N; Tavil Y; Erdamar H; Yazici HU; Cakir E; Akgül EO; Bilgi C; Erbil MK; Poyraz F; Okyay K; Turfan M; Cemri M
Anadolu Kardiyol Derg; 2009 Oct; 9(5):371-9. PubMed ID: 19819787
[TBL] [Abstract][Full Text] [Related]
38. Dimethylarginine dimethylaminohydrolase 2 regulates nitric oxide synthesis and hemodynamics and determines outcome in polymicrobial sepsis.
Lambden S; Kelly P; Ahmetaj-Shala B; Wang Z; Lee B; Nandi M; Torondel B; Delahaye M; Dowsett L; Piper S; Tomlinson J; Caplin B; Colman L; Boruc O; Slaviero A; Zhao L; Oliver E; Khadayate S; Singer M; Arrigoni F; Leiper J
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1382-92. PubMed ID: 25857313
[TBL] [Abstract][Full Text] [Related]
39. Nebivolol ameliorates asymmetric dimethylarginine-induced vascular response in rat aorta via β3 adrenoceptor-mediated mechanism.
Wang Y; Dong X
Clin Exp Hypertens; 2016; 38(2):252-9. PubMed ID: 26825432
[TBL] [Abstract][Full Text] [Related]
40. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.
Gupta S; Wright HM
Cardiovasc Ther; 2008; 26(3):189-202. PubMed ID: 18786089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
